159 related articles for article (PubMed ID: 29296225)
21. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation.
Xiao Z; Wei Z; Deng D; Zheng Z; Zhao Y; Jiang S; Zhang D; Zhang LJ; Fan M; Chen S; Wang S; Ding Y; Ye Y; Jiao H
Cancer Cell Int; 2020; 20():50. PubMed ID: 32082080
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of KLK8 predicts poor prognosis in colorectal cancer.
Liu X; Quan B; Tian Z; Xi H; Jia G; Wang H; Zhang L; Liu R; Ma C; Han F; Li H; Yuan F
Biomed Pharmacother; 2017 Apr; 88():595-602. PubMed ID: 28142115
[TBL] [Abstract][Full Text] [Related]
25. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer.
Li T; Xiong Q; Zou Z; Lei X; Jiang Q; Liu D
Oncotarget; 2017 Dec; 8(70):115153-115163. PubMed ID: 29383149
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
28. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
30. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylase kinase β affects colorectal cancer cell growth and represents a novel prognostic biomarker.
Wang G; Shen W; Liu CY; Liu Y; Wu T; Cui X; Yu T; Zhu Y; Song J; Du P; Cui L
J Cancer Res Clin Oncol; 2017 Jun; 143(6):971-980. PubMed ID: 28275865
[TBL] [Abstract][Full Text] [Related]
32. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
33. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX
World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737
[TBL] [Abstract][Full Text] [Related]
34. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
36. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
38. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.
He X; Lin X; Cai M; Fan D; Chen X; Wang L; Wu X; Lan P; Wang J
Virchows Arch; 2017 Jan; 470(1):37-45. PubMed ID: 27771769
[TBL] [Abstract][Full Text] [Related]
39. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
40. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
